We are live on ! Find out more
BWLSA

Blue Water Life Science Advisors Portfolio holdings

AUM $159M
1-Year Est. Return 139.66%
This Fund
S&P 500
This Quarter Est. Return
+64.12%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
AUM
$159M
AUM Growth
+$34M
Cap. Flow
-$29M
Cap. Flow %
-18.29%
Top 10 Hldgs %
100%
Holding
10
New
Increased
3
Reduced
4
Closed
1

Top Buys

Rank Stock Value
1
CDNA icon
CareDx
CDNA
+$5.55M
2
BLLN
BillionToOne Inc
BLLN
+$4.57M
3
QTRX icon
Quanterix
QTRX
+$4.32M

Top Sells

Rank Stock Value
1
GH icon
Guardant Health
GH
+$13.9M
2
TWST icon
Twist Bioscience
TWST
+$13.1M
3
TXG icon
10x Genomics
TXG
+$11.7M
4
TEM
Tempus AI
TEM
+$2.56M
5
NTRA icon
Natera
NTRA
+$2.2M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDNA icon
1
CareDx
CDNA
$2.41B
$33.9M 21.36%
1,190,000
+255,000
+27% +$5.55M
TXG icon
2
10x Genomics
TXG
$8.1B
$24.6M 15.5%
642,000
-448,000
-41% -$11.7M
PSNL icon
3
Personalis
PSNL
$1.69B
$22.5M 14.15%
1,676,300
ADPT icon
4
Adaptive Biotechnologies
ADPT
$4.07B
$21.7M 13.65%
1,010,145
GH icon
5
Guardant Health
GH
$21.9B
$17.2M 10.84%
114,747
-127,500
-53% -$13.9M
QTRX icon
6
Quanterix
QTRX
$140M
$15M 9.45%
3,474,202
+1,332,055
+62% +$4.32M
NTRA icon
7
Natera
NTRA
$46.9B
$9.36M 5.9%
34,494
-10,300
-23% -$2.2M
BLLN
8
BillionToOne Inc
BLLN
$4.33B
$8.4M 5.29%
70,000
+50,000
+250% +$4.57M
TEM
9
Tempus AI
TEM
$11.1B
$6.11M 3.85%
105,412
-51,000
-33% -$2.56M
TWST icon
10
Twist Bioscience
TWST
$8.93B
-276,000
Closed -$13.1M

Similar funds

Blue Water Life Science Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Blue Water Life Science Advisors held 10 positions worth $159M, up 27% from $125M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Blue Water Life Science Advisors withdrew a net $29M in Q2 2026, closing 1 position and reducing 4 holdings. Its most notable exit was Twist Bioscience, an estimated $13.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Blue Water Life Science Advisors added an estimated $5.55M to CareDx.

  • Blue Water Life Science Advisors added most to CareDx in Q2 2026, an estimated $5.55M increase.
  • Blue Water Life Science Advisors's biggest Q2 2026 reduction was Guardant Health, cutting an estimated $13.9M.
  • Blue Water Life Science Advisors fully exited Twist Bioscience in Q2 2026, selling an estimated $13.1M.
  • Blue Water Life Science Advisors's ten largest holdings make up 100% of its $159M portfolio in Q2 2026.
  • Blue Water Life Science Advisors opened 0 new positions and closed 1 in Q2 2026.
  • Blue Water Life Science Advisors's portfolio value rose 27% quarter-over-quarter to $159M.

Based on Blue Water Life Science Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.